Literature DB >> 392485

Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole.

M Borgers, M De Brabander, H Van Den Bossche, J Van Cutsem.   

Abstract

The effects of miconazole and its new derivative ketoconazole on Candida albicans have been evaluated by light and electron microscopy. The growth characteristics and morphology of C. albicans in culture for various periods of time in a solution consisting of Eagle's minimum essential medium supplemented with amino acids and fetal calf serum are emphasized. This medium, normally used for culturing mammalian cells, promotes a rather fast growth of C. albicans and favours the development of pseudomycelium. The obvious interest in using such culture conditions for drug evaluation is the prevalence of pseudomycelium, which in vivo is the predominant pathological form of C. albicans. Suppression of pseudomycelium formation is found in the 10-9 to 10-7 M concentration range of the imidazoles. Growth retardation and the destruction of both yeast and pseudomycelial forms brought about by incubating the cells with 10-9 to 10-4 M of the drugs are reported. At low doses these changes include the alteration of cell division, an increase in cell volume and a progressive deterioration of subcellular organelles at the cell periphery. At higher doses the involvement of all other organelles is observed finally leading to complete cell necrosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 392485      PMCID: PMC2425661          DOI: 10.1136/pgmj.55.647.687

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans.

Authors:  H van den Bossche; G Willemsens; W Cools; W F Lauwers; L Le Jeune
Journal:  Chem Biol Interact       Date:  1978-04       Impact factor: 5.192

2.  The ultrastructure of Candida albicans after in vitro treatment with miconazole.

Authors:  S De Nollin; M Borgers
Journal:  Sabouraudia       Date:  1974-11

3.  An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.

Authors:  K L Lee; H R Buckley; C C Campbell
Journal:  Sabouraudia       Date:  1975-07

4.  Ketoconazole -- a new broad spectrum orally active antimycotic.

Authors:  D Thienpont; J Van Cutsem; F Van Gerven; J Heeres; P A Janssen
Journal:  Experientia       Date:  1979-05-15

5.  The preservation of subcellular organelles of Candida albicans with conventional fixatives.

Authors:  M Borgers; S De Nollin
Journal:  J Cell Biol       Date:  1974-08       Impact factor: 10.539

  5 in total
  10 in total

1.  Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.

Authors:  N D Lees; M C Broughton; D Sanglard; M Bard
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

2.  The host and the parasite.

Authors:  J Symoens
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

Review 3.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

4.  Critical role of germ tube formation in the pathogenesis of candidal vaginitis.

Authors:  J D Sobel; G Muller; H R Buckley
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

5.  Effect of Candida morphology on amphotericin B susceptibility.

Authors:  K M Nugent; K R Couchot; L D Gray
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

6.  In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.

Authors:  H Van den Bossche; G Willemsens; W Cools; F Cornelissen; W F Lauwers; J M van Cutsem
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

7.  Comparative antibacterial activity of Vancocin and generic vancomycin.

Authors:  J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

8.  Effects of subinhibitory concentrations of ketoconazole on in vitro adherence of Candida albicans to vaginal epithelial cells.

Authors:  J D Sobel; N Obedeanu
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

9.  Anticandidal activities of terconazole, a broad-spectrum antimycotic.

Authors:  E L Tolman; D M Isaacson; M E Rosenthale; J L McGuire; J Van Cutsem; M Borgers; H Van den Bossche
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

10.  Ultrastructural changes produced by ketoconazole in the yeast-like phase of Paracoccidioides brasiliensis and Histoplasma capsulatum.

Authors:  M B Negroni de Bonvehi; M Borgers; R Negroni
Journal:  Mycopathologia       Date:  1981-05-08       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.